Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback